About Us
Established in March,2015 with a registered capital of CNY 77 million,Jining Zhongzaisheng Huahui Pharmaceutical Technology Co.,Ltd.is a branch of Zhongzaisheng Environment Technology Co.,Ltd.,a wholly as owned subsidiary of China Renewable Resources Development Co.,Ltd.in Shandong Province. Our company is located in Zoucheng Industrial Park of Shandong Province, with an area of 66,033 square meters and a construction area of 28,000 square meters, including 8 production and auxiliary plants, 17 R&D centers, quality inspection centers and other supporting units. With a complete quality management system, high as standard analytical testing laboratory and domestic first as class management and operation team, our company is mainly engaged in the research and development, production and sales of pharmaceutical intermediates, including sulbactam acid, triphenylchloromethane and pyridine hydrochloride, etc; they are involving in anti-infectives, anti-AIDS, anti-tumor and cardiovascular pharmaceutical intermediates. There are 210 employees working for our company now, including 41 R&D personnel (accounting for 20% of the total number of employees) and 12 technicians with middle and senior titles.
Our company always adheres to the "people-oriented" concept of safe production; through adopting an advanced DCS control system, we have successfully realized the automation of the production process to ensure that the process control is accurate, safe and efficient. We also established a R&D platform of pharmaceutical intermediate and a multi-functional pilot plant, which can carry out a variety of unit reactions to batch-incubate and produce multi-variety and high-value-added products. We also have established an open R&D system and actively carried out industry-university-research cooperation. Up to now, our company has already docked with many universities, research institutes, and well-known pharmaceutical companies and opened up channels for R&D, production, and sales.
Adhering to the development concept of "reduction, circulation, and reclamation", our company has successfully achieved the comprehensive extraction and utilization of all wastewater, special recycling of all auxiliary agents, as well as the recycling of all raw materials by adopting international advanced technologies and equipment such as MVR evaporation system, MBR membrane bioreaction technology, electrocatalytic oxidation technology and UASB anaerobic tower, etc.
Our company adheres to the business policy of "taking market as oriented, service as purpose, getting survival by excellent quality and further development by technology, and taking innovation as driving force" , and strives to create a "safe, environment-friendly, efficient, and standardized" R&D platform and production base of pharmaceutical intermediate; we are committed to being a leader in the pharmaceutical intermediate industry of China.
